Gene · 688
Papers3,365
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,365
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting Triple Negative Breast Cancer With Oncolytic Adenoviruses. | Front Mol Biosci | 2022 | 35813830 | PubTator, text mining | PubMed |
| Genome-wide Meta-analysis Reveals New Gene Signatures and Potential Drug Targets of Hypertension. | ACS Omega | 2022 | 35811894 | PubTator, text mining | PubMed |
| The trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine inhibits lipopolysaccharide-induced inflammation transcriptomic pathways and cytokine secretion in a macrophage cell model. | Toxicol In Vitro | 2022 | 35811015 | PubTator, text mining | PubMed |
| LncRNA SNHG6 accelerates hyperoxia-induced lung cell injury via regulating miR-335 to activate KLF5/NF-κB pathway. | Cytokine | 2022 | 35809451 | PubTator, text mining | PubMed |
| Epigenetic and Transcriptomic Programming of HSC Quiescence Signaling in Large for Gestational Age Neonates. | Int J Mol Sci | 2022 | 35806330 | PubTator, text mining | PubMed |
| Therapeutic Targeting of Ovarian Cancer Stem Cells Using Estrogen Receptor Beta Agonist. | Int J Mol Sci | 2022 | 35806169 | PubTator, text mining | PubMed |
| Breast Cancer Genomics: Primary and Most Common Metastases. | Cancers (Basel) | 2022 | 35804819 | PubTator, text mining | PubMed |
| Extracellular Vesicles and Their Associated miRNAs as Potential Biomarkers in Intracranial Aneurysm. | Front Mol Biosci | 2022 | 35795823 | PubTator, text mining | PubMed |
| A review on the role of MCM3AP-AS1 in the carcinogenesis and tumor progression. | Cancer Cell Int | 2022 | 35790972 | PubTator, text mining | PubMed |
| LncRNAs in breast cancer: a link to future approaches. | Cancer Gene Ther | 2022 | 35788171 | PubTator, text mining | PubMed |
| Restoring the epigenetically silenced lncRNA COL18A1-AS1 represses ccRCC progression by lipid browning via miR-1286/KLF12 axis. | Cell Death Dis | 2022 | 35787628 | PubTator, text mining | PubMed |
| Deciphering Pro-angiogenic Transcription Factor Profiles in Hypoxic Human Endothelial Cells by Combined Bioinformatics and in vitro Modeling. | Front Cardiovasc Med | 2022 | 35783871 | PubTator, text mining | PubMed |
| Therapeutic Response of miR-145 Micelles on Patient-Derived Vascular Smooth Muscle Cells. | Front Digit Health | 2022 | 35783597 | PubTator, text mining | PubMed |
| A WWP2-PTEN-KLF5 signaling axis regulates odontoblast differentiation and dentinogenesis in mice. | J Biol Chem | 2022 | 35780838 | PubTator, text mining | PubMed |
| hsa_circ_0115355 promotes pancreatic β-cell function in patients with type 2 diabetes through the miR-145/SIRT1 axis. | J Clin Lab Anal | 2022 | 35778952 | PubTator, text mining | PubMed |
| Survivin, sonic hedgehog, krüppel-like factors, and p53 pathway in serous ovarian cancer: an immunohistochemical study. | Hum Pathol | 2022 | 35777700 | PubTator, text mining | PubMed |
| Acetyl-Coenzyme A Synthetase 2 Potentiates Macropinocytosis and Muscle Wasting Through Metabolic Reprogramming in Pancreatic Cancer. | Gastroenterology | 2022 | 35777482 | PubTator, text mining | PubMed |
| Regulation of both transcription and RNA turnover contribute to germline specification. | Nucleic Acids Res | 2022 | 35776114 | PubTator, text mining | PubMed |
| KLF5-induced miR-487a augments the progression of osteosarcoma cells by targeting NKX3-1 in vitro. | Oncol Lett | 2022 | 35765275 | PubTator, text mining | PubMed |
| MiR-21 regulating PVT1/PTEN/IL-17 axis towards the treatment of infectious diabetic wound healing by modified GO-derived biomaterial in mouse models. | J Nanobiotechnology | 2022 | 35764963 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/688/papers?page=46